Bcr/Abl-negative myeloproliferative neoplasia (MPN) is characterized by driver mutations in MPL, CALR, or JAK2, as well as an inflammatory microenvironment. The acquisition of clonal abnormalities and secondary mutations in MPN patients can progress the disease to Acute Myeloid Leukemia (AML), resulting in bone marrow (BM) fibrosis and BM failure. For these patients, treatment options fall short and do not include approaches to prevent leukemic transformation. Our group has developed an animal model for inflammation where loss of RBPJ/Notch signaling in the BM niche leads to upregulation of miR155 and an accumulation of proinflammatory cytokines. We propose to use this model (RBPJKO mouse) to study the influence of chronic inflammation on JAK2V617F-driven MPN progression. We hypothesize that chronic inflammation in the BM niche: i) promotes proliferation and genomic instability in hematopoietic cells; and ii) cooperates with preexisting genetic mutations such as JAK2V617F to promote clonal expansion and selection, accelerating disease progression. Our preliminary studies indicate that JAK2V617F hematopoietic cells drive a more aggressive disease when exposed to chronic inflammation following transplant into RBPJKO inflamed BM niches. Indeed, JAK2V617F/RBPJKO recipients exhibited accelerated neutrophilia, higher myeloid skewing and increased bone marrow cellularity and splenomegaly, when compared to JAK2V617F/RBPJWT recipients. By using alkaline comet assay and gH2Ax foci, we also demonstrate that JAK2V617F cooperates with the inflamed BM niche to promote more DNA single- and double-strand breaks in Lin- progenitors in vivo. To further study these events, we optimized an in vitro model in which WT and JAK2V617F BM Lin- progenitors are co-cultured with RBPJKO or RBPJWT BM-derived stroma. JAK2V617F cells showed increased proliferation, mitochondrial ROS accumulation, elevated 53BP1 foci and increased γH2AX MFI when exposed to the inflammatory conditions supported by RBPJKO stroma. Taken together, these data suggest that chronic inflammation can accentuate the MPN phenotype, promote replicative stress and lead to buildup of DNA-damaging ROS in JAK2V617F MPN cells. This work has the potential to provide us with new insights into the mechanisms of MPN progression and the opportunity to identify new therapeutic approaches.